← Open Payments lookup

LAURA WALLS: Open Payments

NPI 1497192595 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$347 in 16 payments from 8 companies in 2025. Trend: 2023 $18 · 2024 $0 · 2025 $347

Food & beverage: $347
CompanyPaymentsAmount
ABBVIE INC.5$118
Novo Nordisk Inc4$81
Janssen Pharmaceuticals, Inc2$35
Gilead Sciences, Inc.1$30
Otsuka America Pharmaceutical, Inc.1$25
Merck Sharp & Dohme LLC1$22
Boehringer Ingelheim Pharmaceuticals, Inc.1$21
Lilly USA, LLC1$15

Products named: VRAYLAR, SPRAVATO, Ozempic, UBRELVY, QULIPTA, Wegovy, REXULTI, VAXELIS.

Industry payments across CO — which companies pay providers there.